Targeted imaging of lung cancer with hyperpolarized 129Xe MRI using surface-modified iron oxide nanoparticles as molecular contrast agents

Kimura, A. orcid.org/0000-0001-5702-276X, Utsumi, S., Shimokawa, A. et al. (5 more authors) (2022) Targeted imaging of lung cancer with hyperpolarized 129Xe MRI using surface-modified iron oxide nanoparticles as molecular contrast agents. Cancers, 14 (24). 6070. ISSN 2072-6694

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: hyperpolarized 129Xe MRI; murine lung cancer; targeted imaging; molecular targeting contrast agent
Dates:
  • Accepted: 7 December 2022
  • Published (online): 9 December 2022
  • Published: December 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease
Depositing User: Symplectic Sheffield
Date Deposited: 11 Jan 2023 15:22
Last Modified: 11 Jan 2023 15:22
Published Version: http://dx.doi.org/10.3390/cancers14246070
Status: Published
Publisher: MDPI AG
Refereed: Yes
Identification Number: https://doi.org/10.3390/cancers14246070
Related URLs:

Export

Statistics